Doximity, Inc.
DOCS Healthcare Health Information Services
Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.
- Revenue
- +3.57%
- EPS
- −42.4%
- Free cash flow
- +1.87%
Quarter to September 2026, against a year earlier
Follow DOCS
Alert me
Doximity, Inc. (DOCS) P/E ratio
As of 5 November 2026, Doximity, Inc. (DOCS) trades at a P/E ratio of 44.4×. Over the past ten years it has ranged from 17.3× (May 2026) to 132× (September 2021); the current reading is higher than 46% of that period. That is above the Health Information Services industry median of 42.0× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 22.4× | (54.06%) |
| FY2025 | 48.8× | 45.87% |
| FY2024 | 33.4× | (39.09%) |
| FY2023 | 54.9× | (19.19%) |
| FY2022 | 67.9× | (13.45%) |
| FY2021 | 78.5× | 0.00% |
| FY2020 | 78.5× | 0.00% |
| FY2019 | 78.5× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 37.8× | 62.15% |
| Jun 2026 | 23.3× | 4.02% |
| Mar 2026 | 22.4× | (35.74%) |
| Dec 2025 | 34.9× | (36.13%) |
| 23 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| TEM Tempus AI, Inc. compare | n/m |
| HTFL Heartflow, Inc. compare | n/m |
| SDGR Schrodinger, Inc. compare | n/m |
| BTSG BrightSpring Health Services, Inc. compare | 33.0× |
| HQY HealthEquity, Inc. compare | 36.9× |
| WAY Waystar Holding Corp. compare | 40.9× |
| DOCS Doximity, Inc. | 44.4× |
| HNGE Hinge Health Inc. compare | 86.1× |
| PRVA Privia Health Group, Inc. compare | 88.3× |
| Health Information Services industry median | 42.0× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on DOCS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement